NK:IO raises £1.2M, bringing total Seed funding to £5.1M, to advance pioneering NK cell therapy

FHS
July 25, 2023
9:06 am

New investment of £1.2M brings total Seed funding to £5.1M including Innovate UK grants of £1.9M.

BRAF-MEK Inhibition Achieves ‘Near Universal’ Response in Rare Brain Tumor

Targeted BRAF-MEK inhibition resulted in a response in nearly all patients with untreated BRAF V600E–mutated papillary craniopharyngioma, according to results from a small phase II

July 13, 2023

Partnership deals for psychedelic drugs take a trip with 500% surge in 2023 – Pharmaceutical Technology

Share this article Source: GlobalData, Pharma Intelligence Center, Deals Database (Accessed 22 November 2023) ©GlobalData YTD = year to date Note: Includes all announced and

December 1, 2023

U.S. News Releases ‘Best Children’s Hospitals’ Amid Ongoing Criticism

As U.S. News & World Report rolled out its annual list of “Best Children’s Hospitals,” the outlet also received new pushback on its rankings. On

June 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.